90,71 €
100,79 €
-10% with code: EXTRA
Regulating Medicines in Europe
Regulating Medicines in Europe
90,71
100,79 €
  • We will send in 10–14 business days.
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations, it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democ…
100.79
  • Publisher:
  • ISBN-10: 0415208785
  • ISBN-13: 9780415208789
  • Format: 14 x 21.6 x 1.4 cm, minkšti viršeliai
  • Language: English
  • SAVE -10% with code: EXTRA

Regulating Medicines in Europe (e-book) (used book) | bookbook.eu

Reviews

Description

This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations, it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance

EXTRA 10 % discount with code: EXTRA

90,71
100,79 €
We will send in 10–14 business days.

The promotion ends in 22d.03:13:15

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 1,01 Book Euros!?
  • Author: John Abraham
  • Publisher:
  • ISBN-10: 0415208785
  • ISBN-13: 9780415208789
  • Format: 14 x 21.6 x 1.4 cm, minkšti viršeliai
  • Language: English English

This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations, it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)